Martin Imhof

Martin Imhof

Auto-generated profile, based on publicly available information

Martin Imhof

Landsteiner Institute for Cell-Oriented Therapy in Gynecology, Austria

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2016 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
MLMarkus Lipovac
Markus Lipovac
FBFlorian Bodner
Florian Bodner
MIMartin Imhof
Martin Imhof
PCPeter Chedraui
Peter Chedraui
There are reports showing that l-carnitine alone or in combination with other micronutrients improve sperm parameters. However, comparative studies are still lacking. This study was carried out to compare the short term effects of a combination of eight micronutrients including l-carnitine vs. a mono-substance (l-carnitine alone) on sperm parameters. This was a prospective, open-labelled, nonrandomized study that included male subjects (20 to 60 years) with at least 1 year of subfertility and at least one pathological semen analysis who received 3 months treatment with a mono-substance (500 mg l-carnitine/twice a day, n = 156) or a combined compound (440 mg l-carnitine + 250 mg l-arginine + 40 mg zinc + 120 mg vitamin E + 80 mg glutathione + 60 μg selenium + 15 mg coenzyme Q10 + 800 μg folic acid/once a day, n = 143) for the same time period. Sperm parameters were analyzed before and after treatment and groups comparisons performed. Baseline characteristics were similar among studied groups (age and body mass indices). Semen parameters (volume, density, overall progressive motility [including slow and fast motility]) and percentage of sperm with normal morphology improved after 3 months in both groups as compared to baseline. However, relative change (expressed as % increase of absolute values) for sperm density and overall progressive motility (including fast motility) was found to be higher for the combined micronutrient treatment group as compared to the mono-treatment using l-carnitine alone. Both analyzed groups displayed a positive short term effect on all sperm parameters; however effect on density and motility was significantly better for the combined formulation. There is need for more research in this matter that includes long term outcome data. Retrospectively registered at ISRCTN (7th October 2016). Study ID: ISRCTN48594239

1 November 2011 in Obstetrics and Gynecology International
Verified
Journal Article
Open access
PDF file
MLMarkus Lipovac
Markus Lipovac
PCPeter Chedraui
Peter Chedraui
CGChristine Gruenhut
Christine Gruenhut
AGAnca Gocan
Anca Gocan
CKChristine Kurz
Christine Kurz
MIMartin Imhof
Martin Imhof
Objective. Evaluate in postmenopausal women the effect of red clover extract (RCE) isoflavones over subjective status of skin, appendages, and several mucosal sites.Method. Postmenopausal women (n=109) were randomly assigned to receive either two daily capsules of the active compound (80 mg RCE, Group A) or placebo of equal appearance (Group B) for a 90-day period. After a washout period of 7 days, medication was crossed over and taken for 90 days more. Subjective improvement of skin, appendages, and several mucosal site status was assessed for each studied group at 90 and 187 days using a visual analogue scale (VAS). In addition, libido, tiredness, and urinary, sleep, and mood complaints were also evaluated.Results. Women after RCE intervention (both groups) reported better subjective improvement of scalp hair and skin status, libido, mood, sleep, and tiredness. Improvement of urinary complaints, nail, body hair, and mucosa (oral, nasal, and ocular) status did not differ between treatment phases (intra- and intergroup). Overall satisfaction with treatment was reported higher after RCE intervention (both groups) as compared to placebo.Conclusion. RCE supplementation exerted a subject improvement of scalp hair and skin status as well as libido, mood, sleep, and tiredness in postmenopausal women.

1 November 2002 in British Journal of Surgery
Verified
Journal Article
Closed access
MIM. Imhof
M. Imhof
JZJ. Zacherl
J. Zacherl
ARA. Rais
A. Rais
MLM. Lipovac
M. Lipovac
RJR. Jakesz
R. Jakesz
RFR. Fuegger
R. Fuegger
To evaluate the safety of elective laparoscopic cholecystectomy (LC) as a supervised teaching procedure. Prospectively documented series, retrospective analysis. University teaching hospital, Austria. 581 consecutive patients who underwent elective LC for symptomatic cholelithiasis between January 1993 and December 1997. LC were allocated to three groups: the first (n = 91) were done by supervised beginners (who had done fewer than 11 LC), the second (n = 249) by supervised trainees who had a little experience (they had done more than 10 but fewer than 51 LC), and the third group (n = 241) who were experienced surgeons (they had done more than 50 LC). Minor and major complications, conversion and reoperation rate, length of operation and postoperative hospital stay. The minor intraoperative complication rates were 36/91 (40%), 115/249 (46%) and 49/241 (20%), respectively (p < 0.001 when experienced surgeons were compared with the 2 trainees' groups). There were no significant differences between the three groups regarding major complications (1/91, 4/249 and 4/241), conversions (5/91, 21/249, and 17/241) and reoperation rate (1/91, 3/249 and 3/241), median (range) length of operation 82 (24-159), 84 (25-249) and 82 (21-234) minutes and hospital stay 4 (3-19), 4 (3-11) and 4 (2-15) days. Elective LC for symptomatic cholelithiasis done by trainees under supervision does not increase surgical morbidity.

Verified
Journal Article
Open access
PDF file
JAJudith Aschauer
Judith Aschauer
MSMichaela Sima
Michaela Sima
MIMartin Imhof
Martin Imhof
Objective: This study aims to evaluate the safety and efficacy of a standard micronutrient preparation to improve semen parameters and seminal oxidative stress in adult male subjects after Coronavirus Disease 2019 (COVID-19) disease. Methods: For this prospective pilot study, 30 males aged 20-50 years who had recently recovered from a symptomatic SARS-CoV-2 infection were recruited from June to October 2021 through a public call for participation. Participants of the study group (n = 30) received two semen analyses according to WHO criteria at an interval of 12 weeks, during which they daily received a micronutrient preparation (L-carnitine, L-arginine, coenzyme Q10, vitamin E, zinc, folic acid, glutathione and selenium). Changes in major semen variables and seminal oxidative stress levels before and after therapy were analyzed and compared to a control group (n = 10) adhering to the same inclusion criteria, including subjects who recently recovered from symptomatic COVID-19 disease without micronutrient supplementation within the 12 weeks between the two semen analyses. Results: After 3 months of micronutrient supplementation the rate of normal semen analysis results in the study group increased significantly (p = 0.009) by 66.7%: from 50.0% before to 83.3% after therapy. There was a significant increase in progressive (p = 0.014) and overall motility (p = 0.05) as well as in the vitality (p = 0.0004) of semen cells after 12 weeks of micronutrient intake. In the control group there were no significant changes in any semen parameter or in the rate of normal semen analysis results over the 3-month observation period. In both groups, sperm density, morphology and oxidative stress did not improve significantly. Conclusions: Our data suggests that supplementation of certain micronutrients may be a safe way to support recovery of impaired semen parameters in male adults recovered from COVID-19 disease.

1 January 2026 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
MBMaria Julia Bauer
Maria Julia Bauer
HHHannah Halát
Hannah Halát
PCPeter Chedraui
Peter Chedraui
MLMarkus Lipovac
Markus Lipovac
MIMartin Imhof
Martin Imhof
AJAna Mitrovic Jovanovic
Ana Mitrovic Jovanovic
SUMMARY BACKGROUND: Infertility affects 10–15% of couples worldwide. Although assisted reproductive technologies such as in vitro fertilization are effective, they are invasive, costly, and not without risks. Nutraceutical supplementation has gained importance as a non-invasive option to support natural conception. OBJECTIVE: The aim of this study was to evaluate whether combined nutraceutical supplementation improves natural pregnancy rates in subfertile couples with a relative indication for in vitro fertilization while awaiting treatment. METHODS: This retrospective study included 213 couples followed for 6 months (119 in the supplementation group; 94 controls). In the treatment group, both partners received combined nutraceutical supplementation (PROfertil® female/male). Controls received folic acid for women only, while men received no treatment. All couples were on an in vitro fertilization waiting list without an absolute indication for immediate assisted reproductive technologies. Those with oligoasthenozoospermia II/III or bilateral tubal occlusion were excluded. The primary endpoint was a natural pregnancy within 6 months. RESULTS: Natural conception occurred more often in the supplementation group than in controls (66.4 vs. 39.4%, p<0.001). Multivariate logistic regression showed a 4.13-fold higher odds of pregnancy with supplementation (95%CI 2.12–8.04, p<0.001). CONCLUSION: Combined nutraceutical supplementation significantly increased natural pregnancy rates in couples awaiting in vitro fertilization. Randomized trials are needed to confirm these findings and assess live birth outcomes.